September 1, 2010, Mats Warstedt takes on the position as CEO of Innovativ Vision AB in Sweden, the world´s leading supplier of the WoodEye scanning equipment for the wood processing industry.
Henrik31/08/2010
Priveq Investment becomes one of the new main owners of Carmel Pharma AB, a world leader in closed drug transfer systems for handling of hazardous drugs, such as cytostatics. Other main shareholders are Investor Growth Capital, Industrifonden, Start Invest and…
Henrik07/05/2009
Priveq Investment is becoming a partner of Mediplast AB, a leader in consumables for healthcare. In 2009, Mediplast had sales of approximately SEK 310 m and has traced high growth through recent years. In tandem with Priveq’s investment, capital is…
Henrik29/07/2010
-“In the midst of a tough exit market, we achieved our best exit ever and contributed to the creation of a new Swedish specialist pharmaceutical company with great international potential,” said Louise Nilsson, Partner and Investment Manager of Priveq Investment.
Henrik23/04/2010
Priveq investment has as of today closed the exit transaction made on November 5th, 2009, thus sealing the outcome of the most successful exit, money multiple-wise, of our 27 years of history. The transaction was conditioned by a positive outcome…
Henrik14/01/2010
As part of the Swedish Government sell-off of its former pharmacy monopoly, Priveq Investment and Investor Growth Capital are acquiring the pharmacies in clusters 6 and 7 offered by Apoteket Omstrukturering AB through newly incorporated entity Vårdapoteket i Norden AB.…
Henrik09/11/2009
Priveq has entered an agreement to divest its holding in pharmaceuticals company Swedish Orphan International to Biovitrum today, creating Swedish Orphan Biovitrum AB.
Henrik05/11/2009